Indeed, studies have shown that BRAF mutation status influences the treatment response in human cancers [51,52], and there is evidence for a different therapeutic response when comparing BRAF mutated vs. non-mutated canine cancers [35,53,54]. The gene discussed is BRAF; the disease is cancer.